What's breaking now, across thousands of outlets.
This under-the-radar AI chipmaker just landed a multi-year OpenAI deal, and investors are taking notice.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Key PointsThe iShares U.S. Healthcare ETF offers a lower expense ratio and a higher dividend yield than the iShares Biotechnology ETF.
BANGKOK — Finance ministers and central bankers meet in Bangkok this week for the annual gatherings of the International Monetary Fund (IMF) and World Bank, with the global economy buffeted between…
TME has the extremes. Extreme markets: The AI takeover The numbers are becoming extraordinary. AI now dominates US equity returns, earnings growth and investment spending.
